---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289469850.md"
description: "Theriva Biologics shares are trading higher after the company announced the publication of clinical, translational results from VCN-01's Phase 1 clinical trial in Head & Neck Squamous Cell Carcinoma in Clinical Cancer Research journal."
datetime: "2026-06-11T12:46:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289469850.md)
  - [en](https://longbridge.com/en/news/289469850.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289469850.md)
generator: "portal-rs"
---

# 

Theriva Biologics shares are trading higher after the company announced the publication of clinical, translational results from VCN-01's Phase 1 clinical trial in Head & Neck Squamous Cell Carcinoma in Clinical Cancer Research journal.

### Related Stocks

- [TOVX.US](https://longbridge.com/en/quote/TOVX.US.md)

## Related News & Research

- [VERAXA Biotech (NASDAQ: VRXA) Builds Antibody-Based Cancer Pipeline Around Dual-Targeting Precision](https://longbridge.com/en/news/296815081.md)
- [Moderna Just Doubled on a Massive Cancer Breakthrough. Here’s Why MRNA Stock Isn’t a Buy Yet.](https://longbridge.com/en/news/296643850.md)
- [Lotus Lake portfolio company Immupeutics wins China IND clearance for IPM514 mRNA vaccine in lung squamous cancer](https://longbridge.com/en/news/296847935.md)
- [iSpecimen ships hundreds of cancer blood specimens for international research order within three weeks](https://longbridge.com/en/news/296531044.md)
- [Biovica says DiviTum TKa study in metastatic melanoma is published in Clinical Cancer Research](https://longbridge.com/en/news/296871354.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**